Hims & Hers Health (HIMS) Asset Utilization Ratio (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Asset Utilization Ratio came in at 1.07 in Q1 2026, down 51.97% year-on-year from 2.23 in Q1 2025, and little changed quarter-over-quarter from 1.07 in Q4 2025.
Hims & Hers Health (HIMS) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 1.07 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 1.07, down 51.97% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.07 (down 51.97% YoY), and the FY2025 annual result was 1.64, down 36.19% from the prior year.
- Asset Utilization Ratio came in at 1.07 for Q1 2026 at Hims & Hers Health, roughly flat from 1.07 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 2.3 in Q2 2024 to a low of 0.8 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 1.66 (2023), against an average of 1.63.
- Across the five-year window, Asset Utilization Ratio surged 117.47% in 2022 and sank 53.11% in 2025, its largest moves.
- Hims & Hers Health's Asset Utilization Ratio stood at 1.41 in 2022, then soared by 45.0% to 2.04 in 2023, then grew by 10.54% to 2.25 in 2024, then plunged by 52.54% to 1.07 in 2025, then gained by 0.17% to 1.07 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.07 (Q1 2026), 1.07 (Q4 2025), and 1.08 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.36 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.68 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.07 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 0.79 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 |
| Dec 31, 2025 | 1.07 |
| Sep 30, 2025 | 1.08 |
| Jun 30, 2025 | 1.45 |
| Mar 31, 2025 | 2.23 |
| Dec 31, 2024 | 2.25 |
| Sep 30, 2024 | 2.29 |
| Jun 30, 2024 | 2.30 |
| Mar 31, 2024 | 2.16 |
| Dec 31, 2023 | 2.04 |
| Sep 30, 2023 | 1.97 |
| Jun 30, 2023 | 1.86 |
| Mar 31, 2023 | 1.66 |
| Dec 31, 2022 | 1.41 |
| Sep 30, 2022 | 1.17 |
| Jun 30, 2022 | 0.98 |
| Mar 31, 2022 | 0.80 |
| Dec 31, 2021 | 0.65 |
| Sep 30, 2021 | 0.60 |
| Jun 30, 2021 | 0.56 |